(Q46502899)
Statements
1 reference
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies (English)
1 reference
Kurtzberg J
1 reference
Ernst TJ
1 reference
Keating MJ
1 reference
Gandhi V
1 reference
Hodge JP
1 reference
Kisor DF
1 reference
Lager JJ
1 reference
Stephens C
1 reference
Levin J
1 reference
Krenitsky T
1 reference
Elion G
1 reference
Mitchell BS
1 reference
1 May 2005
1 reference
1 reference
23
1 reference
15
1 reference
3396-3403
1 reference
Identifiers
1 reference
1 reference